<DOC>
	<DOCNO>NCT01199536</DOCNO>
	<brief_summary>The Study purpose evaluate Helicobacter pylori susceptibility Clarithromycin estimate eradication heal rate duodenal ulcer routine eradication therapy end treatment 52 week therapy start</brief_summary>
	<brief_title>Helicobacter Pylori Eradication Treatment Patients With Duodenal Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<criteria>Active duodenal ulcer duodenal ulcer exacerbation confirm endoscopic sign duodenal ulcer disease ( acute ulcer scar deformity duodenal bulb ) anamnesis data . Helicobacter pylori positive diagnosis entry 13CUrea Breath Test ( UBT ) Prescription standard 7day eradication therapy include esomeprazole 20 mg bd , amoxicillin 1000 mg bd , clarithromycin 500 mg bd Written inform consent provide prior start participation study . Subjects unwilling unable provide inform consent Current complication duodenal ulcer disease , e.g . perforation , bleed pyloric stenosis History esophageal/gastric/duodenal surgery except patient underwent perforated ulcer closure endoscopic hemostasis 6 month ago Contraindications Esomeprazole , Amoxicillin Clarythromycin include know suspected hypersensitivity allergy Treatment Amoxicillin , Clarythromycin Bismuth contain drug one month prior inclusion Two previous attempt eradicate H. Pylori</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Helicobacter-positive duodenal ulcer</keyword>
</DOC>